Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Rossari BiotechQ1 FY27Chemicals & Petrochemicals
Home/Stocks/Rossari Biotech/Q1 FY27

Rossari Biotech Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹506P/E: 18.4Market Cap: ₹2.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

No information is provided regarding the same in the latest conference call.

Margin guidance

No information is provided regarding the same in the latest conference call.

3 more insights locked — sign up free to unlock

Fundraise plans

No information is provided regarding the same in the latest conference call.

Order book

No information is provided regarding the same in the latest conference call.

Capex plans

No information is provided regarding the same in the latest conference call.

How does Rossari Biotech rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Rossari Biotech
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does Rossari Biotech rank in Chemicals & Petrochemicals?

Compare Rossari Biotech against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Other quarters — Rossari Biotech

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
Rossari Biotech full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Rossari Biotech's management said in earlier quarters

  • Q4 FY26 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q2 FY26 earnings call analysis →
  • Q1 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fine Organic (Q3 FY26)

    Investment of approximately INR 700-750 crores for Phase 1. Key concall takeaways from Fine Organic's Q3 FY26 earnings call — and how it ranks against sector…

  • NOCIL (Q4 FY26)

    The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…

  • Indo Borax & Chemicals Ltd (Q4 FY26)

    175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF